rss

Early data on Gilead coronavirus medicine remdesivir is very encouraging

Antiviral medicine remdesivir is being used to treat cov1 COVID-19 patients at a Chicago hospital,

A small study only, and note: The lack of a control arm in the study could make interpreting the results more challenging, so not leaping to conclusions:
  • The University of Chicago Medicine recruited 125 people with Covid-19
  • two Phase 3 clinical trials
  • 113 had severe disease
  • All the patients been treated with daily infusions of remdesivir
  • “The best news is that most of our patients have already been discharged, which is great. We’ve only had two patients perish,” said Kathleen Mullane, the University of Chicago infectious disease specialist overseeing the remdesivir studies for the hospital.
Pic via Wikipedia:
Antiviral medicine remdesivir is being used to treat cov1 COVID-19 patients at a Chicago hospital, 

WSJ on “promising drug combination” to treat coronavirus, and the “new data supporting this treatment”

The Wall Street Journal on Hydroxychloroquine and azithromycin.

Physicians are using two drugs in combination
  • hydroxychloroquine and azithromycin
to treat patients with advanced Covid-19 symptoms
Kansas City area physicians … continue to treat many patients, and some have shown improvement. Major medical centers including the University of Washington and Mass General have added hydroxychloroquine to treatment options. So here’s an update, a response to some questions that have come up, and suggestions based on the latest information.
Here is the link to the article for more info – its far too detailed to go into here.